Gudjon Karason - Ssur Hf Ex Clinics
| OSSUY Stock | USD 4.05 0.00 0.00% |
Insider
Gudjon Karason is Ex Clinics of ssur hf
| Age | 54 |
| Phone | 354 515 1300 |
| Web | https://www.ossur.com |
Ssur Hf Management Efficiency
The company has return on total asset (ROA) of 0.0326 % which means that it generated a profit of $0.0326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0685 %, meaning that it generated $0.0685 on every $100 dollars invested by stockholders. Ssur Hf's management efficiency ratios could be used to measure how well Ssur Hf manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Gregory Ahlberg | Abbott Laboratories | 54 | |
| Todd Brinton | Edwards Lifesciences Corp | N/A | |
| A Harrison | Koninklijke Philips NV | 57 | |
| Daveen Chopra | Edwards Lifesciences Corp | 45 | |
| Christopher Toth | Siemens Healthineers AG | 44 | |
| Sean Carney | Koninklijke Philips NV | N/A | |
| John Ginascol | Abbott Laboratories | 62 | |
| John Liddicoat | Medtronic PLC | 56 | |
| Andrea Wainer | Abbott Laboratories | 55 | |
| Catherine Jennings | Boston Scientific Corp | N/A | |
| Kevin Lofton | Medtronic PLC | 65 | |
| Andrew Pierce | Stryker | 50 | |
| Michel DVM | Siemens Healthineers AG | 62 | |
| Jennifer Kirk | Medtronic PLC | 49 | |
| Sean Lennon | Medtronic PLC | N/A | |
| M Fink | Stryker | 51 | |
| Carsten Bertram | Siemens Healthineers AG | N/A | |
| Elaine Leavenworth | Abbott Laboratories | 65 | |
| Paul Flynn | DexCom Inc | 55 | |
| Brett Wall | Medtronic PLC | 58 | |
| Rachel Ellingson | Zimmer Biomet Holdings | 54 | |
Management Performance
| Return On Equity | 0.0685 | |||
| Return On Asset | 0.0326 |
ssur hf Leadership Team
Elected by the shareholders, the Ssur Hf's board of directors comprises two types of representatives: Ssur Hf inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ssur. The board's role is to monitor Ssur Hf's management team and ensure that shareholders' interests are well served. Ssur Hf's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ssur Hf's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christian Robinson, Ex Americas | ||
| Margret Fridriksdottir, Exec Strategy | ||
| Sigurborg Arnarsdottir, Compliance Officer | ||
| Olafur Gylfason, Ex Markets | ||
| Edda Luovigsdottir, Investor Director | ||
| Sveinn Solvason, Pres CEO | ||
| Ossur Kristinsson, Founder | ||
| Gudny Sveinsdottir, Chief Officer | ||
| Egill Jonsson, Ex Operations | ||
| Gudjon Karason, Ex Clinics |
Ssur Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ssur Hf a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0685 | |||
| Return On Asset | 0.0326 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 2.3 B | |||
| Shares Outstanding | 420.29 M | |||
| Price To Earning | 145.20 X | |||
| Price To Book | 2.53 X | |||
| Price To Sales | 2.62 X | |||
| Revenue | 718.65 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ssur Pink Sheet Analysis
When running Ssur Hf's price analysis, check to measure Ssur Hf's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ssur Hf is operating at the current time. Most of Ssur Hf's value examination focuses on studying past and present price action to predict the probability of Ssur Hf's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ssur Hf's price. Additionally, you may evaluate how the addition of Ssur Hf to your portfolios can decrease your overall portfolio volatility.